✦ LIBER ✦

Correlates of depressed mood in ambulatory head and neck cancer patients

✍ Scribed by Akira Kugaya; Tatsuo Akechi; Hitoshi Okamura; Ichiro Mikami; Yosuke Uchitomi

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 58 KB
Volume: 8
Category: Article
ISSN: 1057-9249
DOI: 10.1002/(sici)1099-1611(199911/12)8:6<494::aid-pon403>3.0.co;2-m

No coin nor oath required. For personal study only.

✦ Synopsis

High levels of psychological distress, especially depressed mood, has been discussed in relation to head and neck cancer. Patients with head and neck cancer face functional impairment and disfigurement caused by cancer and/or its treatment. Psychosocial factors that predict depressed mood in this population have not been well elucidated. The aim of this study is to examine the psychosocial and medical risk factors for depressed mood in ambulatory head and neck cancer patients. Depressed mood and coping style were assessed with the Profile of Mood States (POMS) and the Mental Adjustment to Cancer (MAC) scales, respectively, in 99 ambulatory head and neck cancer patients. Simultaneously, patients' social support and satisfaction with it, and sociodemographic and medical data were obtained. Multiple regression analysis revealed that advanced disease, being unmarried, and helpless/hopeless coping were significantly associated with depressed mood. The results suggest that we should identify these factors and target psychosocial intervention for those patients most at risk.

📜 SIMILAR VOLUMES

Osseointegrated implants in the head and

Osseointegrated implants in the head and neck cancer patient

✍ Michael A. McGhee; Scott J. Stern; Donald Callan; Kristopher Shewmake; Tom Smith 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

Background. Osseointegrated implants allow patients with oromandibular defects to obtain complete or partial dentition via implant-assisted or implant-borne prostheses. Implants restore masticatory and occlusal function, improving oral intake and articulation. However, use of implants in head and ne

Tissue oxygen distribution in head and n

Tissue oxygen distribution in head and neck cancer patients

✍ Markus F. Adam; Edward C. Gabalski; Daniel A. Bloch; John W. Oehlert; J. Martin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## Background: The importance of hypoxia in limiting the sensitivity of tumor cells to ionizing radiation has long been known. ## Methods: We evaluated the tissue oxygenation status with a polarographic needle electrode system in 37 patients with malignancies of the head and neck and correlated t

Second neoplasm in patients with head an

Second neoplasm in patients with head and neck cancer

✍ Xavier León; Miquel Quer; Santiago Diez; Cesar Orús; Antonio López-Pousa; Joaqui 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

Background. The improvement in locoregional control of head and neck carcinomas over the last decades does not appear to modify the final survival of these patients, mainly due to the appearance of distant metastases and second neoplasms. We ran a study to evaluate the incidence of second neoplasms

Intravenous hyperalimentation in patient

Intravenous hyperalimentation in patients with head and neck cancer

✍ Dr. Edward M. Copeland; Bruce V. MacFadyen Jr; William S. MacComb; Oscar Guillam 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 1 views

Smoking withdrawal and relapse in head a

Smoking withdrawal and relapse in head and neck cancer patients

✍ Ellen R. Gritz; Chris Schacherer; Laura Koehly; Ingrid R. Nielsen; Elliot Abemay 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

Background. Smoking withdrawal and relapse were characterized among newly diagnosed head and neck cancer patients participating in a physician-delivered smoking cessation intervention. Methods. Patients completed questionnaires at baseline, 1, 6, and 12 months following intervention delivery. Resu

9p21 deletion correlates with recurrence

9p21 deletion correlates with recurrence in head and neck cancer

✍ William M. Lydiatt; Bruce J. Davidson; Stimson P. Schantz; Salvatore Caruana; Ra 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 1 views

## Background: Deletion of 9p21 is a common event in many human tumors, including head and neck squamous cell carcinoma (hnscc). the gene cdkn2, which encodes the protein p16, a cyclin-dependent kinase-4 inhibitor, maps to 9p21. the role of cdkn2 as the tumor suppressor gene in these neoplasms is u